Hepion Pharmaceuticals, Inc. (HEPA): Bathi resik saben saham sajrone 12 wulan pungkasan

Simbol lan logo merek Hepion Pharma (HEPA)

Hepion Pharmaceuticals strictly adheres to environmental regulations regarding chemical disposal in its laboratories. Meanwhile, geopolitical instability complicates patent protection and global supplies, as clearly demonstrated by the annual net income per share chart, where the figure stood at -82.03. Business development is based on the strategic outsourcing of clinical trials for liver drugs through external contractors.

HEPA (Hepion Pharmaceuticals) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 14.06.2025

Rincian analitis perusahaan Hepion Pharma (HEPA)

Analisis dhasar perusahaan:HEPA - Hepion Pharmaceuticals, Inc.
Produk sing diprodhuksi Hepion Pharmaceuticals Inc.

Analyzing the rolling earnings per share trend, we see the current state of the biotech issuer Hepion Pharmaceuticals (HEPA). This indicator reflects the net income remainder distributed across the total volume of issued securities for the year. The metric is sensitive to operating losses and the volume of equity capital. For a company in the liquidation stage following failed clinical trials, this figure captures the cash burn rate. The negative trend confirms a critical crisis in the business model.